{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:35:18Z","timestamp":1792856118090,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T00:00:00Z","timestamp":1575936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T00:00:00Z","timestamp":1575936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Fuzhenghuayu (FZHY) is a compound extracted from natural plants. Its anti-fibrotic effect has been confirmed in experimental and clinical studies. However, precise effects and underlying mechanisms of FZHY in liver angiogenesis largely remain understood. In this study, we investigated the effects of FZHY on sinusoidal capillarization and angiogenesis with mice challenged for Carbon tetrachloride (CCl<jats:sub>4<\/jats:sub>) and dimethylnitrosamine (DMN), <jats:italic>in vitro<\/jats:italic> human hepatic sinusoidal endothelial cells (HHSEC) and Human Umbilical Vein Endothelial Cell (HUVEC) 3D fibrin gel model. Besides its anti-fibrotic effect, FZHY ameliorated CCl<jats:sub>4<\/jats:sub> and DMN-induced sinusoidal capillarization, angiogenesis and expression of angiogenesis-associated factors, i.e. CD31, VEGF, VEGF receptor II, phosphor-ERK and HIF-1\u03b1. Consistent with the findings based on animal models, inhibitory effects of FZHY on capillarization and angiogenesis were further confirmed in HHSEC and the HUVEC 3D fibrin gel model, respectively. These data suggest that FZHY ameliorates not only liver fibrosis but also vessel remodeling in experimental models. Therefore, FZHY might be a potentially useful drug to treat liver cirrhosis in clinical practice.<\/jats:p>","DOI":"10.1038\/s41598-019-54663-4","type":"journal-article","created":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T11:03:32Z","timestamp":1575975812000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Fuzhenghuayu Decoction ameliorates hepatic fibrosis by attenuating experimental sinusoidal capillarization and liver angiogenesis"],"prefix":"10.1038","volume":"9","author":[{"given":"Hong-liang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-min","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An-ming","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"Glenn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-yan","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-lei","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-hai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,10]]},"reference":[{"key":"54663_CR1","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1002\/hep.25545","volume":"55","author":"H Sahin","year":"2012","unstructured":"Sahin, H. et al. Chemokine Cxcl9 attenuates liver fibrosis-associated angiogenesis in mice. Hepatology (Baltimore, Md.) 55, 1610\u20131619, https:\/\/doi.org\/10.1002\/hep.25545 (2012).","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"54663_CR2","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1002\/hep.27332","volume":"61","author":"E Seki","year":"2015","unstructured":"Seki, E. & Schwabe, R. F. Hepatic inflammation and fibrosis: functional links and key pathways. Hepatology (Baltimore, Md.) 61, 1066\u20131079, https:\/\/doi.org\/10.1002\/hep.27332 (2015).","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"54663_CR3","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1172\/jci66028","volume":"123","author":"D Schuppan","year":"2013","unstructured":"Schuppan, D. & Kim, Y. O. Evolving therapies for liver fibrosis. The Journal of clinical investigation 123, 1887\u20131901, https:\/\/doi.org\/10.1172\/jci66028 (2013).","journal-title":"The Journal of clinical investigation"},{"key":"54663_CR4","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1056\/NEJMc1504848","volume":"373","author":"ML Urban","year":"2015","unstructured":"Urban, M. L., Manenti, L. & Vaglio, A. Fibrosis\u2013A Common Pathway to Organ Injury and Failure. The New England journal of medicine 373, 95\u201396, https:\/\/doi.org\/10.1056\/NEJMc1504848 (2015).","journal-title":"The New England journal of medicine"},{"key":"54663_CR5","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jhep.2016.07.009","volume":"66","author":"J Poisson","year":"2017","unstructured":"Poisson, J. et al. Liver sinusoidal endothelial cells: Physiology and role in liver diseases. Journal of hepatology 66, 212\u2013227, https:\/\/doi.org\/10.1016\/j.jhep.2016.07.009 (2017).","journal-title":"Journal of hepatology"},{"key":"54663_CR6","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1002\/hep.22351","volume":"48","author":"LD Deleve","year":"2008","unstructured":"Deleve, L. D., Wang, X. & Guo, Y. Sinusoidal endothelial cells prevent rat stellate cell activation and promote reversion to quiescence. Hepatology (Baltimore, Md.) 48, 920\u2013930, https:\/\/doi.org\/10.1002\/hep.22351 (2008).","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"54663_CR7","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1111\/jcmm.13158","volume":"21","author":"X Li","year":"2017","unstructured":"Li, X. et al. Placental growth factor silencing ameliorates liver fibrosis and angiogenesis and inhibits activation of hepatic stellate cells in a murine model of chronic liver disease. Journal of cellular and molecular medicine 21, 2370\u20132385, https:\/\/doi.org\/10.1111\/jcmm.13158 (2017).","journal-title":"Journal of cellular and molecular medicine"},{"key":"54663_CR8","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1002\/hep.27376","volume":"61","author":"LD DeLeve","year":"2015","unstructured":"DeLeve, L. D. Liver sinusoidal endothelial cells in hepatic fibrosis. Hepatology (Baltimore, Md.) 61, 1740\u20131746, https:\/\/doi.org\/10.1002\/hep.27376 (2015).","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"54663_CR9","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.jhep.2014.05.047","volume":"61","author":"Y Iwakiri","year":"2014","unstructured":"Iwakiri, Y., Shah, V. & Rockey, D. C. Vascular pathobiology in chronic liver disease and cirrhosis - current status and future directions. Journal of hepatology 61, 912\u2013924, https:\/\/doi.org\/10.1016\/j.jhep.2014.05.047 (2014).","journal-title":"Journal of hepatology"},{"key":"54663_CR10","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/j.1478-3231.2010.02369.x","volume":"31","author":"S Coulon","year":"2011","unstructured":"Coulon, S. et al. Angiogenesis in chronic liver disease and its complications. Liver international: official journal of the International Association for the Study of the Liver 31, 146\u2013162, https:\/\/doi.org\/10.1111\/j.1478-3231.2010.02369.x (2011).","journal-title":"Liver international: official journal of the International Association for the Study of the Liver"},{"key":"54663_CR11","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1055\/s-0030-1255355","volume":"30","author":"O Rosmorduc","year":"2010","unstructured":"Rosmorduc, O. & Housset, C. Hypoxia: a link between fibrogenesis, angiogenesis, and carcinogenesis in liver disease. Seminars in liver disease 30, 258\u2013270, https:\/\/doi.org\/10.1055\/s-0030-1255355 (2010).","journal-title":"Seminars in liver disease"},{"key":"54663_CR12","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s10456-015-9468-3","volume":"18","author":"S Srinivasan","year":"2015","unstructured":"Srinivasan, S. et al. Hypoxia-induced expression of phosducin-like 3 regulates expression of VEGFR-2 and promotes angiogenesis. Angiogenesis 18, 449\u2013462, https:\/\/doi.org\/10.1007\/s10456-015-9468-3 (2015).","journal-title":"Angiogenesis"},{"key":"54663_CR13","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.2353\/ajpath.2007.060887","volume":"170","author":"E Novo","year":"2007","unstructured":"Novo, E. et al. Proangiogenic cytokines as hypoxia-dependent factors stimulating migration of human hepatic stellate cells. The American journal of pathology 170, 1942\u20131953 (2007).","journal-title":"The American journal of pathology"},{"key":"54663_CR14","unstructured":"Alastair, D., Burt, B. C. P. & Ferrel, L. D. MacSween\u2019s Pathology of the Liver 6th edition (2012)."},{"key":"54663_CR15","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.jhep.2004.03.007","volume":"40","author":"VJ Desmet","year":"2004","unstructured":"Desmet, V. J. & Roskams, T. Cirrhosis reversal: a duel between dogma and myth. Journal of hepatology 40, 860\u2013867, https:\/\/doi.org\/10.1016\/j.jhep.2004.03.007 (2004).","journal-title":"Journal of hepatology"},{"key":"54663_CR16","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1002\/hep.21921","volume":"46","author":"S Tugues","year":"2007","unstructured":"Tugues, S. et al. Antiangiogenic treatment with sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats. Hepatology (Baltimore, Md.) 46, 1919\u20131926, https:\/\/doi.org\/10.1002\/hep.21921 (2007).","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"54663_CR17","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/j.1476-5381.2009.00158.x","volume":"157","author":"M Hennenberg","year":"2009","unstructured":"Hennenberg, M. et al. Sorafenib targets dysregulated Rho kinase expression and portal hypertension in rats with secondary biliary cirrhosis. British journal of pharmacology 157, 258\u2013270, https:\/\/doi.org\/10.1111\/j.1476-5381.2009.00158.x (2009).","journal-title":"British journal of pharmacology"},{"key":"54663_CR18","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1002\/hep.22758","volume":"49","author":"M Mejias","year":"2009","unstructured":"Mejias, M. et al. Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats. Hepatology (Baltimore, Md.) 49, 1245\u20131256, https:\/\/doi.org\/10.1002\/hep.22758 (2009).","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"54663_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1749-8546-4-12","volume":"4","author":"C Liu","year":"2009","unstructured":"Liu, C., Hu, Y., Xu, L., Liu, C. & Liu, P. Effect of Fuzheng Huayu formula and its actions against liver fibrosis. Chinese medicine 4, 12, https:\/\/doi.org\/10.1186\/1749-8546-4-12 (2009).","journal-title":"Chinese medicine"},{"key":"54663_CR20","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.3748\/wjg.v11.i19.2892","volume":"11","author":"P Liu","year":"2005","unstructured":"Liu, P. et al. Multicenter clinical study on Fuzhenghuayu capsule against liver fibrosis due to chronic hepatitis B. World journal of gastroenterology 11, 2892\u20132899 (2005).","journal-title":"World journal of gastroenterology"},{"issue":"5","key":"54663_CR21","first-page":"S","volume":"146","author":"Tarek Hassanein","year":"2014","unstructured":"Hassanein, T. B. T., Tong, M. J., Pozza, R., Lorenzo, O., Jeffrey, G. A Phase II, randomized, placebo-controlled, double-blind, multi-center study to assess the antifibrotic activity of FZHY in chronic hepatitis C patients with hepatic fibrosis. Gastroenterology 146 (2014).","journal-title":"Gastroenterology"},{"key":"54663_CR22","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1002\/hep.23478","volume":"51","author":"G Garcia-Tsao","year":"2010","unstructured":"Garcia-Tsao, G., Friedman, S., Iredale, J. & Pinzani, M. Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis. Hepatology (Baltimore, Md.) 51, 1445\u20131449, https:\/\/doi.org\/10.1002\/hep.23478 (2010).","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"54663_CR23","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1038\/nmat5024","volume":"16","author":"L Liu","year":"2017","unstructured":"Liu, L. et al. Mechanotransduction-modulated fibrotic microniches reveal the contribution of angiogenesis in liver fibrosis. Nature materials 16, 1252\u20131261, https:\/\/doi.org\/10.1038\/nmat5024 (2017).","journal-title":"Nature materials"},{"key":"54663_CR24","doi-asserted-by":"publisher","first-page":"935903","DOI":"10.1155\/2015\/935903","volume":"2015","author":"Q Pan","year":"2015","unstructured":"Pan, Q., Wang, Y. Q., Li, G. M., Duan, X. Y. & Fan, J. G. Fuzheng Huayu Recipe Ameliorates Liver Fibrosis by Restoring Balance between Epithelial-to-Mesenchymal Transition and Mesenchymal-to-Epithelial Transition in Hepatic Stellate Cells. BioMed research international 2015, 935903, https:\/\/doi.org\/10.1155\/2015\/935903 (2015).","journal-title":"BioMed research international"},{"key":"54663_CR25","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jep.2012.10.047","volume":"145","author":"Q Cheng","year":"2013","unstructured":"Cheng, Q. et al. Fuzheng Huayu inhibits carbon tetrachloride-induced liver fibrosis in mice through activating hepatic NK cells. Journal of ethnopharmacology 145, 175\u2013181, https:\/\/doi.org\/10.1016\/j.jep.2012.10.047 (2013).","journal-title":"Journal of ethnopharmacology"},{"key":"54663_CR26","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1053\/j.gastro.2011.12.017","volume":"142","author":"G Xie","year":"2012","unstructured":"Xie, G. et al. Role of differentiation of liver sinusoidal endothelial cells in progression and regression of hepatic fibrosis in rats. Gastroenterology 142, 918\u2013927.e916, https:\/\/doi.org\/10.1053\/j.gastro.2011.12.017 (2012).","journal-title":"Gastroenterology"},{"key":"54663_CR27","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1136\/gutjnl-2013-306294","volume":"63","author":"J Ehling","year":"2014","unstructured":"Ehling, J. et al. CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis. Gut 63, 1960\u20131971, https:\/\/doi.org\/10.1136\/gutjnl-2013-306294 (2014).","journal-title":"Gut"},{"key":"54663_CR28","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1002\/hep.25965","volume":"57","author":"T Matsubara","year":"2013","unstructured":"Matsubara, T. et al. TIE2-expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlates with angiogenesis. Hepatology (Baltimore, Md.) 57, 1416\u20131425, https:\/\/doi.org\/10.1002\/hep.25965 (2013).","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"54663_CR29","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1136\/gutjnl-2014-306842","volume":"64","author":"YA Lee","year":"2015","unstructured":"Lee, Y. A., Wallace, M. C. & Friedman, S. L. Pathobiology of liver fibrosis: a translational success story. Gut 64, 830\u2013841, https:\/\/doi.org\/10.1136\/gutjnl-2014-306842 (2015).","journal-title":"Gut"},{"key":"54663_CR30","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1136\/gut.52.9.1347","volume":"52","author":"H Yoshiji","year":"2003","unstructured":"Yoshiji, H. et al. Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis. Gut 52, 1347\u20131354 (2003).","journal-title":"Gut"},{"key":"54663_CR31","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/0003-2697(81)90261-X","volume":"112","author":"IS Jamall","year":"1981","unstructured":"Jamall, I. S., Finelli, V. N. & Que Hee, S. S. A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues. Analytical biochemistry 112, 70\u201375 (1981).","journal-title":"Analytical biochemistry"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-54663-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-54663-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-54663-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T17:09:29Z","timestamp":1671296969000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-54663-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,10]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["54663"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-54663-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,10]]},"assertion":[{"value":"11 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18719"}}